Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

It has been a rough few seasons for Novo Nordisk (NYSE:NVO) investors, as the company’s share price has tumbled some 60% over ...

Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Most dividend yields ...